Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
What you need to know about flu treatments as cases spike across the US- King Charles shares cancer treatment update, says it's a 'personal blessing'
- 5 Must-Attempt Fascinating Dishes from Around the World
- China's Normal Ponders: A Visual Excursion
- Raw oysters linked to ongoing salmonella outbreak infecting 64 across 22 states: CDC
- Nestlé recalls infant formula in 49 countries. See list.
- Astronomers detect black hole blasting winds at incredible speeds
- How 2025 became the year of comet: The rise of interstellar 3I/ATLAS, an icy Lemmon and a cosmic SWAN
- Find the Future of Outsourcing: Exploring the Gig Economy
